Cao Longxiang & family (#1413)
- $ 3 B
- Pharmaceuticals
- China
- M
- 68 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Cao Longxiang chairs Hubei Jumpcan Pharmaceutical, one of China's largest drug companies, specializing in both western and traditional Chinese medicine. Cao's son, Cao Fei, serves as the company's vice chairman. The company went public in 2001 as Hubei Hongcheng General Machinery, before Cao took control in 2013; he now owns more than 60% of the company. Cao was a manager at a cement factory before taking a job with Hubei and served in the Chinese military before entering the pharma business.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Cao Longxiang & family’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Cao Longxiang & family’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $3.0B
(May 4, 2026)
© Iconic Billionaires